Weight Loss Results: What the Data Shows When it comes to shedding pounds, injectable GLP-1s deliver superior results based on extensive clinical trials: Injectable semaglutide (Wegovy ) : 15-17% average body weight loss Injectable tirzepatide (Mounjaro /Zepboun d) : Up to 22.5% average body weight loss FDA-approved oral semaglutide: 13.6-16.6% average body weight loss Compounded ODT formulations : No published clinical trial data available A real-world comparison study found that patients on injectable semaglutide lost 1.62kg more than those on FDA-approved oral semaglutide over 26 weeks, which was not significant
Women of childbearing potential should use effective contraception during treatment, and semaglutide should be discontinued at least 2 months before a planned pregnancy
10.4093/dmj.2013.37.1.22 181 SaitoM.Okamatsu-OguraY.MatsushitaM.WatanabeK.YoneshiroT.Nio-KobayashiJ.et al
Mounjaro isnt covered by Bridge, but if prescribed for type 2 diabetes, it might be covered by Part D
How long reconstituted tirzepatide lasts The standard recommendation is 28 days after reconstitution
Stop when you feel satisfied, not when you feel stuffed